Stay updated with breaking news from Kimo Peluso. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK — Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000 per cent, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday (Jan 23) upheld his lifetime ban. A three-judge panel of the 2nd US Circuit Court of Appeals in Manhattan said a lower court judge acted properly in...
New York federal appeals court rules ‘pharma bro’, 40, who went to prison for fraud, cannot return to pharmaceutical industry
Shkreli, also known as "Pharma Bro," gained notoriety in 2015 when, as the CEO of Turing Pharmaceuticals, he hiked the price of Daraprim from $17.50 to $750 per tablet.
Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime ban. ... -January 23, 2024 at 03:36 pm EST - MarketScreener